Receptor mechanisms mediating the anti-neuroinflammatory effects of endocannabinoid system modulation in a rat model of migraine.
Quick Facts
What This Study Found
Methanandamide reduced CGRP levels and mast cell degranulation in migraine models.
Key Numbers
How They Did This
The study used an in vivo rat model of migraine induced by nitroglycerin and ex vivo hemiskull preparations to assess the effects of cannabinoid modulation.
Why This Research Matters
Understanding how cannabinoids modulate migraine-related inflammation could lead to new therapeutic strategies. This research highlights the potential of cannabinoid receptors as targets for migraine treatment.
What This Study Doesn't Tell Us
The study was conducted in rats, which may limit the applicability of findings to humans. Further research is needed to confirm these effects in human subjects.
Trust & Context
- Original Title:
- Receptor mechanisms mediating the anti-neuroinflammatory effects of endocannabinoid system modulation in a rat model of migraine.
- Published In:
- The European journal of neuroscience, 55(4), 1015-1031 (2022)
- Database ID:
- RPEP-06250
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06250APA
Kilinc, Erkan; Ankarali, Seyit; Torun, Ibrahim Ethem; Dagistan, Yasar. (2022). Receptor mechanisms mediating the anti-neuroinflammatory effects of endocannabinoid system modulation in a rat model of migraine.. The European journal of neuroscience, 55(4), 1015-1031. https://doi.org/10.1111/ejn.14897
MLA
Kilinc, Erkan, et al. "Receptor mechanisms mediating the anti-neuroinflammatory effects of endocannabinoid system modulation in a rat model of migraine.." The European journal of neuroscience, 2022. https://doi.org/10.1111/ejn.14897
RethinkPeptides
RethinkPeptides Research Database. "Receptor mechanisms mediating the anti-neuroinflammatory eff..." RPEP-06250. Retrieved from https://rethinkpeptides.com/research/kilinc-2022-receptor-mechanisms-mediating-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.